High-fructose and high-fat feeding correspondingly lead to the development of lysoPC-associated apoptotic cardiomyopathy and adrenergic signaling-related cardiac hypertrophy

Int J Cardiol. 2016 Jul 15:215:65-76. doi: 10.1016/j.ijcard.2016.03.239. Epub 2016 Apr 13.

Abstract

Background: The heart is a highly adaptive organ that demonstrates remarkable structural, functional, and metabolic remodeling in response to physiological and pathological stimuli. We hypothesize that the heart undergoes differential adaptations in high-fat and high-fructose diet, resulting in a distinct phenotype.

Methods: High-fat and high-fructose diet-induced obese and non-obese insulin resistance (IR) rat models were used to understand how the heart adapts to long-term (12-week) overnutrition.

Results: Rats fed the high-fat diet developed obese IR, whereas high-fructose diet developed non-obese IR. Obese IR rats developed fibrotic hypertrophy with impairment of preload-independent contractility. The sympathetic and renin-angiotensin-aldosterone (RAA) systems and myocardial adrenergic signaling were activated in obese IR rats. Non-obese IR rats developed apoptotic cardiomyopathy with severe systolic dysfunction. Myocardial calcium cycling regulatory proteins (CCRPs) were dysregulated in non-obese IR rats; specifically, troponin I protein expression was downregulated. Moreover, compared with the controls, lipidomics analysis revealed substantial differences in lipid metabolites in non-obese IR and obese IR rats. The overproduction of lysophosphatidylcholine (lysoPC) and fatty acids was observed in non-obese IR rat hearts. A strong correlation was observed between the myocardial lysoPC and plasma troponin I levels. Treatment of cardiomyocytes with lysoPC resulted in cell death in a dose- and time-dependent manner. The overproduction of myocardial lysoPCs was associated with circulating sPLA2 levels.

Conclusion: Obese IR rats developed severe fibrotic hypertrophy with the activation of adrenergic signaling and sympathetic and RAA systems. The sPLA2-lysoPC may play a crucial role in the induction of apoptotic cardiomyopathy in high fructose-induced non-obese IR rats.

Keywords: Apoptotic cardiomyopathy; Fibrotic hypertrophy; Insulin resistance; Lipidomics; Metabolic syndrome.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Cardiomegaly / etiology*
  • Cardiomegaly / metabolism
  • Cardiomegaly / pathology
  • Cardiomyopathies / etiology*
  • Cardiomyopathies / metabolism
  • Cell Survival / drug effects
  • Diet, High-Fat / adverse effects
  • Diet, High-Fat / methods*
  • Dose-Response Relationship, Drug
  • Fatty Acids / metabolism
  • Fructose / administration & dosage*
  • Fructose / adverse effects
  • Insulin Resistance
  • Lysophosphatidylcholines / metabolism*
  • Male
  • Myocytes, Cardiac / drug effects
  • Obesity / etiology
  • Obesity / metabolism
  • Obesity / pathology
  • Rats
  • Renin-Angiotensin System / drug effects
  • Troponin I / metabolism

Substances

  • Fatty Acids
  • Lysophosphatidylcholines
  • Troponin I
  • Fructose